INSPRA
Generic Name/API: eplerenone
Manufacturer: Pfizer
Dosage Forms & Strength & Pack Size:
Tablets: 25 mg, 50 mg, 30’s
Storage:
Store at 25°C (77°F); excursions permitted to 15–30°C (59–86°F).
INSPRA is an aldosterone antagonist indicated for:
•Improving survival of stable patients with symptomatic heart failure with reduced ejection fraction (HFrEF) after an acute myocardial infarction.
•The treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
WARNINGS AND PRECAUTIONS
Hyperkalemia: Patients with decreased renal function, diabetes, proteinuria or patients who are taking
ACEs and ARBs, NSAIDs or moderate CYP3A inhibitors are at increased risk. Monitor serum potassium
levels and adjust dose as needed.
*The contents of this site are for reference only. We do not offer drug procurement service. All information must not be used for any commercial purpose.
